pharmaceuticals-and-healthcare

Global Biosimilars Market Insights, Forecast to 2025


Published On : Sep 2018

Category : Pharmaceutical

No. of Pages : 117 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilars in these regions.
This research report categorizes the global Biosimilars market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Biosimilars market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Biosimilars market based on company, product type, application and key regions.

The various contributors involved in the value chain of Biosimilars include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Biosimilars include
Pfizer
Sandoz International GmbH
Teva Pharmaceuticals Industries
Amgen Inc
Biocon
Dr. Reddys Laboratories
F. Hoffmann-La Roche
Celltrion
Samsung Bioepis

Market Size Split by Type
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
Market Size Split by Application
Oncology
Blood Disorders

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Biosimilars market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Biosimilars submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilars are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global biosimilars market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global biosimilars market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global biosimilars market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global biosimilars market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global biosimilars market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global biosimilars market insights forecast to 2025, including the definition, classification, and industry chain structure of Global biosimilars market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global biosimilars market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global biosimilars market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global biosimilars market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global biosimilars market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global biosimilars market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global biosimilars market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Biosimilars
Figure Global Biosimilars Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Table Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
Table Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Figure Peptides (Glucagon, Calcitonin) Product Picture
Table Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table Global Biosimilars Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Oncology
Figure Blood Disorders
Figure Biosimilars Report Years Considered
Figure Global Biosimilars Market Size 2016-2025 (Million US$)
Figure Global Biosimilars Sales 2016-2025 (K MT)
Table Global Biosimilars Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Biosimilars Sales by Regions 2016-2025 (K MT)
Table Global Biosimilars Sales Market Share by Regions 2016-2025
Figure Global Biosimilars Sales Market Share by Regions 2016-2025
Figure 2017 Global Biosimilars Sales Market Share by Regions
Table Global Biosimilars Revenue by Regions 2016-2025 (Million US$)
Table Global Biosimilars Revenue Market Share by Regions 2016-2025
Figure Global Biosimilars Revenue Market Share by Regions 2016-2025
Figure 2017 Global Biosimilars Revenue Market Share by Regions
Table Global Biosimilars Sales by Manufacturers (2016-2018) (K MT)
Table Global Biosimilars Sales Share by Manufacturers (2016-2018)
Figure Global Biosimilars Sales Share by Manufacturers in 2017
Table Biosimilars Revenue by Manufacturers (2016-2018) (Million US$)
Table Biosimilars Revenue Share by Manufacturers (2016-2018)
Figure Biosimilars Value Share by Manufacturers in 2017
Table Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biosimilars Price (2016-2018) (USD/MT)
Table Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Biosimilars Product Category
Table Date of International Manufacturers Enter into Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars Sales by Type (2016-2025) (K MT)
Table Global Biosimilars Sales Share by Type (2016-2025)
Figure Global Biosimilars Sales Market Share by Type (2016-2025)
Figure Global Biosimilars Sales Market Share by Type in 2017
Table Global Biosimilars Revenue by Type (2016-2025) (Million US$)
Table Global Biosimilars Revenue Share by Type (2016-2025)
Figure Global Biosimilars Revenue Market Share by Type (2016-2025)
Figure Global Biosimilars Revenue Market Share by Type in 2017
Table Biosimilars Price by Type 2013-2018 (USD/MT)
Table Global Biosimilars Sales by Application (2016-2025) (K MT)
Table Global Biosimilars Sales Share by Application (2016-2025)
Figure Global Sales Biosimilars Market Share by Application (2016-2025)
Figure Global Sales Biosimilars Market Share by Application (2016-2025)
Figure North America Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure North America Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table North America Biosimilars Sales by Countries (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilars Sales Market Share by Countries
Table North America Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table North America Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Biosimilars Revenue Market Share by Countries
Figure United States Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure United States Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Canada Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table North America Biosimilars Sales by Type (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 North America Biosimilars Market Share by Type
Table North America Biosimilars Sales by Application (2016-2025) (K MT)
Table North America Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 North America Biosimilars Market Share by Application
Table North America Biosimilars Sales by Company (2016-2018) (K MT)
Table North America Biosimilars Sales Market Share by Company (2016-2018)
Figure North America Biosimilars Sales Market Share by Company in 2017
Figure Europe Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Europe Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Biosimilars Sales by Countries (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilars Sales Market Share by Countries
Table Europe Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Europe Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Biosimilars Revenue Market Share by Countries
Figure Germany Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Germany Biosimilars Revenue Growth Rate (2016-2025) (K MT)
Figure France Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure France Biosimilars Revenue Growth Rate (2016-2025) (K MT)
Figure UK Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure UK Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Italy Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Russia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Biosimilars Sales by Type (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Europe Biosimilars Market Share by Type
Table Europe Biosimilars Sales by Application (2016-2025) (K MT)
Table Europe Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Europe Biosimilars Market Share by Application
Table Europe Biosimilars Sales by Company (2016-2018) (K MT)
Table Europe Biosimilars Sales Market Share by Company (2016-2018)
Figure Europe Biosimilars Sales Market Share by Company in 2017
Figure Asia Pacific Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Biosimilars Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilars Sales Market Share by Countries
Table Asia Pacific Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Biosimilars Revenue Market Share by Countries
Figure China Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure China Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Japan Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Korea Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure India Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure India Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Australia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Biosimilars Sales by Type (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Biosimilars Market Share by Type
Table Asia Pacific Biosimilars Sales by Application (2016-2025) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Biosimilars Market Share by Application
Table Asia Pacific Biosimilars Sales by Company (2016-2018) (K MT)
Table Asia Pacific Biosimilars Sales Market Share by Company (2016-2018)
Figure Asia Pacific Biosimilars Sales Market Share by Company in 2017
Figure Central & South America Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Biosimilars Sales by Countries (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilars Sales Market Share by Countries
Table Central & South America Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Biosimilars Revenue Market Share by Countries
Figure Brazil Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Biosimilars Sales by Type (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Biosimilars Market Share by Type
Table Central & South America Biosimilars Sales by Application (2016-2025) (K MT)
Table Central & South America Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Biosimilars Market Share by Application
Table Central & South America Biosimilars Sales by Company (2016-2018) (K MT)
Table Central & South America Biosimilars Sales Market Share by Company (2016-2018)
Figure Central & South America Biosimilars Sales Market Share by Company in 2017
Figure Middle East and Africa Biosimilars Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Biosimilars Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Sales Market Share by Countries
Table Middle East and Africa Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Revenue Market Share by Countries
Figure GCC Countries Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Biosimilars Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Biosimilars Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Market Share by Type
Table Middle East and Africa Biosimilars Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Biosimilars Market Share by Application
Table Middle East and Africa Biosimilars Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Biosimilars Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Biosimilars Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Sandoz International GmbH Company Details
Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sandoz International GmbH Recent Development
Table Teva Pharmaceuticals Industries Company Details
Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Teva Pharmaceuticals Industries Recent Development
Table Amgen Inc Company Details
Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Amgen Inc Recent Development
Table Biocon Company Details
Table Biocon Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Dr. Reddys Laboratories Company Details
Table Dr. Reddys Laboratories Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Dr. Reddys Laboratories Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Celltrion Company Details
Table Celltrion Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table Samsung Bioepis Company Details
Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Samsung Bioepis Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Biosimilars Value Chain
Table Typical Suppliers of Key Biosimilars Raw Material
Table Biosimilars Customers List
Table Biosimilars Sales Channels
Table Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top